{"id":"https://openalex.org/W2057788173","doi":"https://doi.org/10.1126/science.2953072","title":"D 1 Dopamine Receptor Activation Required for Postsynaptic Expression of D 2 Agonist Effects","display_name":"D 1 Dopamine Receptor Activation Required for Postsynaptic Expression of D 2 Agonist Effects","publication_year":1987,"publication_date":"1987-05-08","ids":{"openalex":"https://openalex.org/W2057788173","doi":"https://doi.org/10.1126/science.2953072","mag":"2057788173","pmid":"https://pubmed.ncbi.nlm.nih.gov/2953072"},"language":"en","primary_location":{"id":"doi:10.1126/science.2953072","doi":"https://doi.org/10.1126/science.2953072","is_oa":false,"landing_page_url":"https://doi.org/10.1126/science.2953072","pdf_url":null,"source":{"id":"https://openalex.org/S3880285","display_name":"Science","issn_l":"0036-8075","issn":["0036-8075","0193-4511","1095-9203"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034511392","display_name":"Judith R. Walters","orcid":"https://orcid.org/0000-0002-9192-5222","observed_orcids":["https://orcid.org/0000-0002-9192-5222"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith R. Walters","raw_affiliation_strings":["Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042611495","display_name":"Debra A. Bergstrom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra A. Bergstrom","raw_affiliation_strings":["Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057997963","display_name":"Joanne H. Carlson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne H. Carlson","raw_affiliation_strings":["Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110587831","display_name":"Thomas N. Chase","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas N. Chase","raw_affiliation_strings":["Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111617703","display_name":"Allen R. Braun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen R. Braun","raw_affiliation_strings":["Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiological Neuropharmacology Section and Pharmacology Section, Experimental Therapeutics Branch, Nationial Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":18.4399,"has_fulltext":false,"cited_by_count":466,"citation_normalized_percentile":{"value":0.99772577,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"236","issue":"4802","first_page":"719","last_page":"722"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.9639999866485596},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":1.0},{"id":"https://openalex.org/keywords/receptor-synergy","display_name":"receptor synergy","score":0.5519999861717224},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.6779999732971191},{"id":"https://openalex.org/keywords/quinpirole","display_name":"quinpirole","score":0.8539999723434448},{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.9129999876022339},{"id":"https://openalex.org/keywords/alpha-methyl-p-tyrosine","display_name":"alpha-methyl-p-tyrosine","score":0.8399999737739563},{"id":"https://openalex.org/keywords/endogenous-dopamine","display_name":"endogenous dopamine","score":0.8939999938011169},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.8460000157356262},{"id":"https://openalex.org/keywords/spontaneous-locomotor-activity","display_name":"spontaneous motor activity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/single-unit-activity","display_name":"single-unit activity","score":0.6439999938011169},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7463421821594238},{"id":"https://openalex.org/C160262196","wikidata":"https://www.wikidata.org/wiki/Q5376331","display_name":"Endogenous agonist","level":5,"score":0.7335717082023621},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7198333144187927},{"id":"https://openalex.org/C2778296116","wikidata":"https://www.wikidata.org/wiki/Q253187","display_name":"Quinpirole","level":4,"score":0.7025067210197449},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.6985050439834595},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.6341431736946106},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5830322504043579},{"id":"https://openalex.org/C197341189","wikidata":"https://www.wikidata.org/wiki/Q863533","display_name":"Postsynaptic potential","level":3,"score":0.5811285376548767},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5648740530014038},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.540926456451416},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.5190309286117554},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5084739923477173},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48368459939956665},{"id":"https://openalex.org/C2778187257","wikidata":"https://www.wikidata.org/wiki/Q464210","display_name":"Basal ganglia","level":3,"score":0.444724440574646},{"id":"https://openalex.org/C24998067","wikidata":"https://www.wikidata.org/wiki/Q4114622","display_name":"Stimulation","level":2,"score":0.4441411793231964},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4308857321739197},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4307461380958557},{"id":"https://openalex.org/C120750228","wikidata":"https://www.wikidata.org/wiki/Q2035393","display_name":"Dopamine receptor D1","level":4,"score":0.36163002252578735},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2681351900100708},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.1623992621898651},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.115273118019104},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07658219337463379}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001058","descriptor_name":"Apomorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001479","descriptor_name":"Basal Ganglia","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004873","descriptor_name":"Ergolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008781","descriptor_name":"Methyltyrosines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D015647","descriptor_name":"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017447","descriptor_name":"Receptors, Dopamine D1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019257","descriptor_name":"Quinpirole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019805","descriptor_name":"alpha-Methyltyrosine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1126/science.2953072","doi":"https://doi.org/10.1126/science.2953072","is_oa":false,"landing_page_url":"https://doi.org/10.1126/science.2953072","pdf_url":null,"source":{"id":"https://openalex.org/S3880285","display_name":"Science","issn_l":"0036-8075","issn":["0036-8075","0193-4511","1095-9203"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science","raw_type":"journal-article"},{"id":"pmid:2953072","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2953072","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science (New York, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.4043000042438507,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1517107662","https://openalex.org/W1581666194","https://openalex.org/W1643311486","https://openalex.org/W1960975817","https://openalex.org/W1966176551","https://openalex.org/W1966308411","https://openalex.org/W1969998712","https://openalex.org/W1976045951","https://openalex.org/W1985695713","https://openalex.org/W1987193373","https://openalex.org/W1994624903","https://openalex.org/W1995079424","https://openalex.org/W2001233326","https://openalex.org/W2002913872","https://openalex.org/W2009579516","https://openalex.org/W2010001782","https://openalex.org/W2017949567","https://openalex.org/W2018498712","https://openalex.org/W2021683549","https://openalex.org/W2028050703","https://openalex.org/W2028697314","https://openalex.org/W2030905853","https://openalex.org/W2044066882","https://openalex.org/W2061805224","https://openalex.org/W2064801484","https://openalex.org/W2067180416","https://openalex.org/W2068020919","https://openalex.org/W2076122547","https://openalex.org/W2086143711","https://openalex.org/W2088878456","https://openalex.org/W2089154427","https://openalex.org/W2091813848","https://openalex.org/W2113320486","https://openalex.org/W2114722814","https://openalex.org/W2127087784","https://openalex.org/W2164975184","https://openalex.org/W2294946349","https://openalex.org/W4239062325","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2088878456","https://openalex.org/W2037506036","https://openalex.org/W2051536308","https://openalex.org/W2105921567","https://openalex.org/W1966734466","https://openalex.org/W2071285421","https://openalex.org/W302020363","https://openalex.org/W1973512436","https://openalex.org/W2054894047","https://openalex.org/W1982176417"],"abstract_inverted_index":{"D1":[0,54,90,102],"and":[1,16,40,68,91,100,124,133],"D2":[2,29,73,92,98,113],"dopamine":[3,51,64,131,135,152],"receptors":[4,114],"exert":[5],"synergistic":[6],"effects":[7,70,81],"on":[8,17],"the":[9,18,26,47,66,72,80,108,120],"firing":[10],"rates":[11],"of":[12,20,28,49,71,82,96,150],"basal":[13,35,125],"ganglia":[14,36,126],"neurons":[15],"expression":[19],"stereotyped":[21],"behavior":[22,123],"in":[23,34,56,122],"rats.":[24],"Moreover,":[25],"ability":[27],"agonists":[30,84,132],"to":[31,52,61],"induce":[32],"changes":[33,121],"single":[37],"unit":[38],"activity":[39,43],"spontaneous":[41],"motor":[42],"is":[44,136],"dependent":[45],"upon":[46],"presence":[48],"endogenous":[50,63,134],"stimulate":[53,88],"receptors;":[55],"rats":[57],"treated":[58],"with":[59],"alpha-methyl-rho-tyrosine":[60],"reduce":[62],"levels,":[65],"neurophysiological":[67],"behavioral":[69],"agonist":[74,99,103],"quinpirole":[75],"are":[76,104,116],"significantly":[77],"attenuated,":[78],"while":[79],"nonselective":[83,130],"like":[85],"apomorphine,":[86],"which":[87,142],"both":[89,151],"receptors,":[93],"or":[94],"combinations":[95],"a":[97,101],"not":[105,137],"attenuated.":[106],"Thus,":[107],"previously":[109],"held":[110],"view":[111],"that":[112,144],"alone":[115],"responsible":[117],"for":[118],"evoking":[119],"output":[127],"induced":[128],"by":[129,139],"supported":[138],"these":[140,145],"results,":[141],"indicate":[143],"phenomena":[146],"require":[147],"concurrent":[148],"stimulation":[149],"receptor":[153],"subtypes.":[154]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}